Intervention

Glutathione

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting1

Common conditions12

Lead sponsors shown4

Clinical trials

4 shown

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLCNCT06896422 · 2025-06-01

The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute ExerciseNCT02948673 · 2016-05-01

Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on InflammationNCT01550432 · 2011-06-01

Glutathione (GSH) In The Treatment of Parkinson's DiseaseNCT01177319 · 2003-09-01

Common conditions

Chemotherapy1 Glutathione1 Hyperlipidemia1 Hypertension1 Insulin Resistance1 Mitochondrial Reactive Oxygen Species Production1 Non-Small Cell Lung Cancer1 Obesity1 Oxidative Stress1 Parkinson's Disease1 PD1 Antibody1 Type 2 Diabetes1

Leading sponsors

Stanford University1 The First Affiliated Hospital of Zhengzhou University1 University of Copenhagen1 University of South Florida1

Trial status mix

COMPLETED3

RECRUITING1

Phase mix

NA2

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.